SECOND FORBEARANCE AND AMENDMENT AGREEMENTSecond Forbearance and Amendment Agreement • September 24th, 2020 • Cosmos Holdings Inc. • Wholesale-drugs, proprietaries & druggists' sundries • New York
This Second Forbearance and Amendment Agreement (“Agreement”) is made and entered into this 23rd day of September, 2020, by and between, Hudson Bay Master Fund Ltd (the “Investor”) and Cosmos Holdings Inc., a Nevada corporation with offices located at 141 West Jackson Blvd, Suite 4236, Chicago, Illinois 60604 (the “Company”) (collectively, the “Parties”).
SECOND FORBEARANCE AND AMENDMENT AGREEMENTSecond Forbearance and Amendment Agreement • October 23rd, 2019 • iFresh Inc • Retail-grocery stores
This Second Forbearance and Amendment Agreement (this “Agreement”), dated as of October 15, 2019 (the “Effective Date”), is entered into by and among NYM Holding, Inc., a Delaware corporation (the “Borrower”), iFresh, Inc., a Delaware corporation (“iFresh”), New York Mart 8 Ave., Inc., a New York corporation (“NYM8”), New York Mart East Broadway Inc., a New York corporation (“NYM E. Broadway”), New York Supermarket East Broadway Inc., a New York corporation (“NYS E. Broadway”), New York Mart Group Inc., a New York corporation (“NYMG”), Ming’s Supermarket, Inc., a Massachusetts corporation (“Ming’s”), New York Mart Mott St., Inc., a New York corporation (“Mott”), New York Mart Roosevelt, Inc., a New York corporation (“Roosevelt”), New York Mart Sunrise, Inc., a Florida corporation (“Sunrise”), Zen Mkt Quincy, Inc., a Massachusetts corporation (“Zen”), Strong America Limited, a New York corporation (“Strong America”), iFresh E. Colonial Inc., a Florida corporation (“E Colonial”), iFresh
SECOND FORBEARANCE AND AMENDMENT AGREEMENTSecond Forbearance and Amendment Agreement • July 18th, 2023 • 9 Meters Biopharma, Inc. • Pharmaceutical preparations
THIS SECOND FORBEARANCE AND AMENDMENT AGREEMENT (this “Agreement”), effective as of June 29, 2023, is by and among HIGH TRAIL SPECIAL SITUATIONS LLC, a Delaware limited liability company (in its capacity as holder, secured party or collateral agent, as applicable, “Purchaser”), 9 Meters Biopharma, Inc., a Delaware corporation (“Issuer”), and NAIA RARE DISEASES, LLC, a Delaware limited liability company (“Guarantor” and, together with Issuer, the “Note Parties”).
